Europe Nivolumab Market Report 2016

December 2016 | 106 pages | ID: E4B6C4F7B06EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Nivolumab

Revenue, means the sales value of Nivolumab

This report studies sales (consumption) of Nivolumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering

• Bayer
• Eli Lilly
• Sanofi
• Roche
• Pfizer
• Merus
• NovImmune SA
• Jounce Therapeutics
• Amgen
• EMD Serono

Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Nivolumab in these countries, from 2011 to 2021 (forecast), like

• Germany
• France
• UK
• Russia
• Italy
• Spain
• Benelux

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on sales, market share and growth rate of Nivolumab in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Europe Nivolumab Market Report 2016

1 NIVOLUMAB OVERVIEW

1.1 Product Overview and Scope of Nivolumab
1.2 Classification of Nivolumab
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Nivolumab
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Nivolumab Market by Countries
  1.4.1 Germany Status and Prospect (2011-2021)
  1.4.2 France Status and Prospect (2011-2021)
  1.4.3 UK Status and Prospect (2011-2021)
  1.4.4 Russia Status and Prospect (2011-2021)
  1.4.5 Italy Status and Prospect (2011-2021)
  1.4.6 Spain Status and Prospect (2011-2021)
  1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Nivolumab (2011-2021)
  1.5.1 Europe Nivolumab Sales and Growth Rate (2011-2021)
  1.5.2 Europe Nivolumab Revenue and Growth Rate (2011-2021)

2 EUROPE NIVOLUMAB BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Europe Nivolumab Market Competition by Manufacturers
  2.1.1 Europe Nivolumab Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Europe Nivolumab Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Nivolumab (Volume and Value) by Type
  2.2.1 Europe Nivolumab Sales and Market Share by Type (2011-2016)
  2.2.2 Europe Nivolumab Revenue and Market Share by Type (2011-2016)
2.3 Europe Nivolumab (Volume and Value) by Countries
  2.3.1 Europe Nivolumab Sales and Market Share by Countries (2011-2016)
  2.3.2 Europe Nivolumab Revenue and Market Share by Countries (2011-2016)
2.4 Europe Nivolumab (Volume) by Application

3 GERMANY NIVOLUMAB (VOLUME, VALUE AND SALES PRICE)

3.1 Germany Nivolumab Sales and Value (2011-2016)
  3.1.1 Germany Nivolumab Sales and Growth Rate (2011-2016)
  3.1.2 Germany Nivolumab Revenue and Growth Rate (2011-2016)
  3.1.3 Germany Nivolumab Sales Price Trend (2011-2016)
3.2 Germany Nivolumab Sales and Market Share by Manufacturers
3.3 Germany Nivolumab Sales and Market Share by Type
3.4 Germany Nivolumab Sales and Market Share by Application

4 FRANCE NIVOLUMAB (VOLUME, VALUE AND SALES PRICE)

4.1 France Nivolumab Sales and Value (2011-2016)
  4.1.1 France Nivolumab Sales and Growth Rate (2011-2016)
  4.1.2 France Nivolumab Revenue and Growth Rate (2011-2016)
  4.1.4 France Nivolumab Sales Price Trend (2011-2016)
4.2 France Nivolumab Sales and Market Share by Manufacturers
4.3 France Nivolumab Sales and Market Share by Type
4.4 France Nivolumab Sales and Market Share by Application

5 UK NIVOLUMAB (VOLUME, VALUE AND SALES PRICE)

5.1 UK Nivolumab Sales and Value (2011-2016)
  5.1.1 UK Nivolumab Sales and Growth Rate (2011-2016)
  5.1.2 UK Nivolumab Revenue and Growth Rate (2011-2016)
  5.1.5 UK Nivolumab Sales Price Trend (2011-2016)
5.2 UK Nivolumab Sales and Market Share by Manufacturers
5.3 UK Nivolumab Sales and Market Share by Type
5.4 UK Nivolumab Sales and Market Share by Application

6 RUSSIA NIVOLUMAB (VOLUME, VALUE AND SALES PRICE)

6.1 Russia Nivolumab Sales and Value (2011-2016)
  6.1.1 Russia Nivolumab Sales and Growth Rate (2011-2016)
  6.1.2 Russia Nivolumab Revenue and Growth Rate (2011-2016)
  6.1.6 Russia Nivolumab Sales Price Trend (2011-2016)
6.2 Russia Nivolumab Sales and Market Share by Manufacturers
6.3 Russia Nivolumab Sales and Market Share by Type
6.4 Russia Nivolumab Sales and Market Share by Application

7 ITALY NIVOLUMAB (VOLUME, VALUE AND SALES PRICE)

7.1 Italy Nivolumab Sales and Value (2011-2016)
  7.1.1 Italy Nivolumab Sales and Growth Rate (2011-2016)
  7.1.2 Italy Nivolumab Revenue and Growth Rate (2011-2016)
  7.1.7 Italy Nivolumab Sales Price Trend (2011-2016)
7.2 Italy Nivolumab Sales and Market Share by Manufacturers
7.3 Italy Nivolumab Sales and Market Share by Type
7.4 Italy Nivolumab Sales and Market Share by Application

8 SPAIN NIVOLUMAB (VOLUME, VALUE AND SALES PRICE)

8.1 Spain Nivolumab Sales and Value (2011-2016)
  8.1.1 Spain Nivolumab Sales and Growth Rate (2011-2016)
  8.1.2 Spain Nivolumab Revenue and Growth Rate (2011-2016)
  8.1.8 Spain Nivolumab Sales Price Trend (2011-2016)
8.2 Spain Nivolumab Sales and Market Share by Manufacturers
8.3 Spain Nivolumab Sales and Market Share by Type
8.4 Spain Nivolumab Sales and Market Share by Application

9 BENELUX NIVOLUMAB (VOLUME, VALUE AND SALES PRICE)

9.1 Benelux Nivolumab Sales and Value (2011-2016)
  9.1.1 Benelux Nivolumab Sales and Growth Rate (2011-2016)
  9.1.2 Benelux Nivolumab Revenue and Growth Rate (2011-2016)
  9.1.9 Benelux Nivolumab Sales Price Trend (2011-2016)
9.2 Benelux Nivolumab Sales and Market Share by Manufacturers
9.3 Benelux Nivolumab Sales and Market Share by Type
9.4 Benelux Nivolumab Sales and Market Share by Application

10 EUROPE NIVOLUMAB MANUFACTURERS ANALYSIS

10.1 Bayer
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Nivolumab Product Type, Application and Specification
    10.1.2.1 Type I
    10.1.2.2 Type II
  10.1.3 Bayer Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.1.4 Main Business/Business Overview
10.2 Eli Lilly
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Nivolumab Product Type, Application and Specification
    10.2.2.1 Type I
    10.2.2.2 Type II
  10.2.3 Eli Lilly Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.2.4 Main Business/Business Overview
10.3 Sanofi
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Nivolumab Product Type, Application and Specification
    10.3.2.1 Type I
    10.3.2.2 Type II
  10.3.3 Sanofi Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.3.4 Main Business/Business Overview
10.4 Roche
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Nivolumab Product Type, Application and Specification
    10.4.2.1 Type I
    10.4.2.2 Type II
  10.4.3 Roche Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.4.4 Main Business/Business Overview
10.5 Pfizer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Nivolumab Product Type, Application and Specification
    10.5.2.1 Type I
    10.5.2.2 Type II
  10.5.3 Pfizer Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.5.4 Main Business/Business Overview
10.6 Merus
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Nivolumab Product Type, Application and Specification
    10.6.2.1 Type I
    10.6.2.2 Type II
  10.6.3 Merus Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.6.4 Main Business/Business Overview
10.7 NovImmune SA
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Nivolumab Product Type, Application and Specification
    10.7.2.1 Type I
    10.7.2.2 Type II
  10.7.3 NovImmune SA Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.7.4 Main Business/Business Overview
10.8 Jounce Therapeutics
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Nivolumab Product Type, Application and Specification
    10.8.2.1 Type I
    10.8.2.2 Type II
  10.8.3 Jounce Therapeutics Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.8.4 Main Business/Business Overview
10.9 Amgen
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Nivolumab Product Type, Application and Specification
    10.9.2.1 Type I
    10.9.2.2 Type II
  10.9.3 Amgen Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.9.4 Main Business/Business Overview
10.10 EMD Serono
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Nivolumab Product Type, Application and Specification
    10.10.2.1 Type I
    10.10.2.2 Type II
  10.10.3 EMD Serono Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
  10.10.4 Main Business/Business Overview

11 NIVOLUMAB MANUFACTURING COST ANALYSIS

11.1 Nivolumab Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Nivolumab

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Nivolumab Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Nivolumab Major Manufacturers in 2015
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 EUROPE NIVOLUMAB MARKET FORECAST (2016-2021)

14.1 Germany Nivolumab Sales Forecast (2016-2021)
14.2 France Nivolumab Sales Forecast (2016-2021)
14.3 UK Nivolumab Sales Forecast (2016-2021)
14.4 Russia Nivolumab Sales Forecast (2016-2021)
14.5 Italy Nivolumab Sales Forecast (2016-2021)
14.6 Spain Nivolumab Sales Forecast (2016-2021)
14.7 Benelux Nivolumab Sales Forecast (2016-2021)
14.8 Europe Nivolumab Sales Forecast by Type (2016-2021)
14.9 Europe Nivolumab Sales Forecast by Application (2016-2021)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Nivolumab
Table Classification of Nivolumab
Figure Europe Sales Market Share of Nivolumab by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Application of Nivolumab
Figure Europe Sales Market Share of Nivolumab by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Germany Nivolumab Revenue and Growth Rate (2011-2021)
Figure France Nivolumab Revenue and Growth Rate (2011-2021)
Figure UK Nivolumab Revenue and Growth Rate (2011-2021)
Figure Russia Nivolumab Revenue and Growth Rate (2011-2021)
Figure Italy Nivolumab Revenue and Growth Rate (2011-2021)
Figure Spain Nivolumab Revenue and Growth Rate (2011-2021)
Figure Benelux Nivolumab Revenue and Growth Rate (2011-2021)
Figure Europe Nivolumab Sales and Growth Rate (2011-2021)
Figure Europe Nivolumab Revenue and Growth Rate (2011-2021)
Table Europe Nivolumab Sales of Key Manufacturers (2015 and 2016)
Table Europe Nivolumab Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Nivolumab Sales Share by Manufacturers
Figure 2016 Nivolumab Sales Share by Manufacturers
Table Europe Nivolumab Revenue by Manufacturers (2015 and 2016)
Table Europe Nivolumab Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Nivolumab Revenue Share by Manufacturers
Table 2016 Europe Nivolumab Revenue Share by Manufacturers
Table Europe Nivolumab Sales and Market Share by Type (2011-2016)
Table Europe Nivolumab Sales Share by Type (2011-2016)
Figure Sales Market Share of Nivolumab by Type (2011-2016)
Figure Europe Nivolumab Sales Growth Rate by Type (2011-2016)
Table Europe Nivolumab Revenue and Market Share by Type (2011-2016)
Table Europe Nivolumab Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Nivolumab by Type (2011-2016)
Figure Europe Nivolumab Revenue Growth Rate by Type (2011-2016)
Table Europe Nivolumab Sales and Market Share by Countries (2011-2016)
Table Europe Nivolumab Sales Share by Countries (2011-2016)
Figure Sales Market Share of Nivolumab by Countries (2011-2016)
Table Europe Nivolumab Revenue and Market Share by Countries (2011-2016)
Table Europe Nivolumab Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Nivolumab by Countries (2011-2016)
Table Europe Nivolumab Sales and Market Share by Application (2011-2016)
Table Europe Nivolumab Sales Share by Application (2011-2016)
Figure Sales Market Share of Nivolumab by Application (2011-2016)
Figure Germany Nivolumab Sales and Growth Rate (2011-2016)
Figure Germany Nivolumab Revenue and Growth Rate (2011-2016)
Figure Germany Nivolumab Sales Price Trend (2011-2016)
Table Germany Nivolumab Sales by Manufacturers (2015 and 2016)
Table Germany Nivolumab Market Share by Manufacturers (2015 and 2016)
Table Germany Nivolumab Sales by Type (2015 and 2016)
Table Germany Nivolumab Market Share by Type (2015 and 2016)
Table Germany Nivolumab Sales by Application (2015 and 2016)
Table Germany Nivolumab Market Share by Application (2015 and 2016)
Figure France Nivolumab Sales and Growth Rate (2011-2016)
Figure France Nivolumab Revenue and Growth Rate (2011-2016)
Figure France Nivolumab Sales Price Trend (2011-2016)
Table France Nivolumab Sales by Manufacturers (2015 and 2016)
Table France Nivolumab Market Share by Manufacturers (2015 and 2016)
Table France Nivolumab Sales by Type (2015 and 2016)
Table France Nivolumab Market Share by Type (2015 and 2016)
Table France Nivolumab Sales by Application (2015 and 2016)
Table France Nivolumab Market Share by Application (2015 and 2016)
Figure UK Nivolumab Sales and Growth Rate (2011-2016)
Figure UK Nivolumab Revenue and Growth Rate (2011-2016)
Figure UK Nivolumab Sales Price Trend (2011-2016)
Table UK Nivolumab Sales by Manufacturers (2015 and 2016)
Table UK Nivolumab Market Share by Manufacturers (2015 and 2016)
Table UK Nivolumab Sales by Type (2015 and 2016)
Table UK Nivolumab Market Share by Type (2015 and 2016)
Table UK Nivolumab Sales by Application (2015 and 2016)
Table UK Nivolumab Market Share by Application (2015 and 2016)
Figure Russia Nivolumab Sales and Growth Rate (2011-2016)
Figure Russia Nivolumab Revenue and Growth Rate (2011-2016)
Figure Russia Nivolumab Sales Price Trend (2011-2016)
Table Russia Nivolumab Sales by Manufacturers (2015 and 2016)
Table Russia Nivolumab Market Share by Manufacturers (2015 and 2016)
Table Russia Nivolumab Sales by Type (2015 and 2016)
Table Russia Nivolumab Market Share by Type (2015 and 2016)
Table Russia Nivolumab Sales by Application (2015 and 2016)
Table Russia Nivolumab Market Share by Application (2015 and 2016)
Figure Italy Nivolumab Sales and Growth Rate (2011-2016)
Figure Italy Nivolumab Revenue and Growth Rate (2011-2016)
Figure Italy Nivolumab Sales Price Trend (2011-2016)
Table Italy Nivolumab Sales by Manufacturers (2015 and 2016)
Table Italy Nivolumab Market Share by Manufacturers (2015 and 2016)
Table Italy Nivolumab Sales by Type (2015 and 2016)
Table Italy Nivolumab Market Share by Type (2015 and 2016)
Table Italy Nivolumab Sales by Application (2015 and 2016)
Table Italy Nivolumab Market Share by Application (2015 and 2016)
Figure Spain Nivolumab Sales and Growth Rate (2011-2016)
Figure Spain Nivolumab Revenue and Growth Rate (2011-2016)
Figure Spain Nivolumab Sales Price Trend (2011-2016)
Table Spain Nivolumab Sales by Manufacturers (2015 and 2016)
Table Spain Nivolumab Market Share by Manufacturers (2015 and 2016)
Table Spain Nivolumab Sales by Type (2015 and 2016)
Table Spain Nivolumab Market Share by Type (2015 and 2016)
Table Spain Nivolumab Sales by Application (2015 and 2016)
Table Spain Nivolumab Market Share by Application (2015 and 2016)
Figure Benelux Nivolumab Sales and Growth Rate (2011-2016)
Figure Benelux Nivolumab Revenue and Growth Rate (2011-2016)
Figure Benelux Nivolumab Sales Price Trend (2011-2016)
Table Benelux Nivolumab Sales by Manufacturers (2015 and 2016)
Table Benelux Nivolumab Market Share by Manufacturers (2015 and 2016)
Table Benelux Nivolumab Sales by Type (2015 and 2016)
Table Benelux Nivolumab Market Share by Type (2015 and 2016)
Table Benelux Nivolumab Sales by Application (2015 and 2016)
Table Benelux Nivolumab Market Share by Application (2015 and 2016)
Table Nivolumab Basic Information List
Table Bayer Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bayer Nivolumab Sales Market Share (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly Nivolumab Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Nivolumab Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Nivolumab Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Nivolumab Sales Market Share (2011-2016)
Table Merus Basic Information List
Table Merus Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merus Nivolumab Sales Market Share (2011-2016)
Table NovImmune SA Basic Information List
Table NovImmune SA Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table NovImmune SA Nivolumab Sales Market Share (2011-2016)
Table Jounce Therapeutics Basic Information List
Table Jounce Therapeutics Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jounce Therapeutics Nivolumab Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Nivolumab Sales Market Share (2011-2016)
Table EMD Serono Basic Information List
Table EMD Serono Nivolumab Sales, Revenue, Price and Gross Margin (2011-2016)
Table EMD Serono Nivolumab Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nivolumab
Figure Manufacturing Process Analysis of Nivolumab
Figure Nivolumab Industrial Chain Analysis
Table Raw Materials Sources of Nivolumab Major Manufacturers in 2015
Table Major Buyers of Nivolumab
Table Distributors/Traders List
Figure Germany Nivolumab Sales and Growth Rate Forecast (2016-2021)
Figure Germany Nivolumab Revenue and Growth Rate Forecast (2016-2021)
Figure France Nivolumab Sales and Growth Rate Forecast (2016-2021)
Figure France Nivolumab Revenue and Growth Rate Forecast (2016-2021)
Figure UK Nivolumab Sales and Growth Rate Forecast (2016-2021)
Figure UK Nivolumab Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Nivolumab Sales and Growth Rate Forecast (2016-2021)
Figure Russia Nivolumab Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Nivolumab Sales and Growth Rate Forecast (2016-2021)
Figure Italy Nivolumab Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Nivolumab Sales and Growth Rate Forecast (2016-2021)
Figure Spain Nivolumab Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Nivolumab Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Nivolumab Revenue and Growth Rate Forecast (2016-2021)
Table Europe Nivolumab Sales Forecast by Type (2016-2021)
Table Europe Nivolumab Sales Forecast by Application (2016-2021)